2016
DOI: 10.1016/j.radonc.2016.09.017
|View full text |Cite
|
Sign up to set email alerts
|

Combined modalities of magnetic resonance imaging, endoscopy and computed tomography in the evaluation of tumor responses to definitive chemoradiotherapy in esophageal squamous cell carcinoma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
18
0

Year Published

2017
2017
2022
2022

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 18 publications
(18 citation statements)
references
References 32 publications
0
18
0
Order By: Relevance
“…Both of them are closer to the GTVp than the GTV MRI and GTV CT . Both the CT and MRI methods are the first imaging choice for the staging of nasopharyngeal carcinoma [34,36,37]. The results of many studies show that diagenetic accuracy of CT and MRI are equal in the detection of abdominal lymph node metastasis, intraluminal mass and pericardial effusion [38,39].…”
Section: Discussionmentioning
confidence: 99%
“…Both of them are closer to the GTVp than the GTV MRI and GTV CT . Both the CT and MRI methods are the first imaging choice for the staging of nasopharyngeal carcinoma [34,36,37]. The results of many studies show that diagenetic accuracy of CT and MRI are equal in the detection of abdominal lymph node metastasis, intraluminal mass and pericardial effusion [38,39].…”
Section: Discussionmentioning
confidence: 99%
“…Notably, few published studies have investigated the clinical value of DWI in evaluating esophageal carcinoma. Several studies have used “whole tumor” ROI data to differentiate malignant and benign nodes in esophageal carcinoma [ 10 , 11 ] and predict RT response [ 12 , 13 ]. Some groups have advocated assessment of only the most enhanced voxels within a tumor, based on the result that the most enhanced ROIs provided more statistically significant differences between responders and non-responders in CRT than whole tumor ROI [ 14 ].…”
Section: Discussionmentioning
confidence: 99%
“…Concurrent chemoradiotherapy (CRT) should be considered for cervical and upper thoracic esophageal cancer (5). Locally advanced esophageal cancer is managed with nCRT, definitive chemoradiotherapy (dCRT), perioperative chemotherapy (for EAC), or esophagectomy (5,43). The use of nCRT in locally advanced esophageal cancer is associated with improved OS and pathological complete response (pCR) (44).…”
Section: Treatmentmentioning
confidence: 99%